Zolbetuximab + CAPOX in 1L claudin-18.2+ (CLDN18.2+)/HER2− locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW Meeting Abstract
| Authors: | Xu, R. H.; Shitara, K.; Ajani, J. A.; Bang, Y. J.; Enzinger, P. C.; Ilson, D. H.; Lordick, F.; Van Cutsem, E.; Gallego Plazas, J.; Huang, J.; Shen, L.; Oh, S. C.; Sunpaweravong, P.; Soo Hoo, H. F.; Turk, H. M.; Park, J. W.; Moran, D. M.; Bhattacharya, P. P.; Arozullah, A.; Shah, M. A. |
| Abstract Title: | Zolbetuximab + CAPOX in 1L claudin-18.2+ (CLDN18.2+)/HER2− locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW |
| Meeting Title: | 2023 ASCO Monthly Plenary Series |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 41 |
| Issue: | 36 Suppl. |
| Meeting Dates: | 2023 Mar |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2023-03-20 |
| Start Page: | 405736 |
| Language: | English |
| DOI: | 10.1200/JCO.2023.41.36_suppl.405736 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cinahl |
| DOI/URL: | |
| Notes: | Meeting abstract: 405736 -- Source: Cinahl |
